Methods for the treatment of wounds using butyric acid salts and

Details Methods for the treatment of wounds using butyric acid salts and Methods for the treatment of wounds using butyric acid salts and

1995-06-07

1999-01-12

Minnifield, Nita

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

4242781, 536115, 536119, 514 12, 514551, 514925, 514926, 514927, 514928, A61K 3900, A61K 3119, A01N 3700, C07H 1100

Patent

active

058583653

ABSTRACT:
This invention is directed to methods of administering physiologically stable and safe compositions of butyric acid salts and derivatives to a patient for the purpose of wound healing.

REFERENCES:
patent: 3471513 (1969-10-01), Chinn et al.
patent: 4008323 (1977-02-01), Cousse et al.
patent: 4011336 (1977-03-01), Amann et al.
patent: 4031243 (1977-06-01), Aparicio et al.
patent: 4058558 (1977-11-01), Cousse et al.
patent: 4131617 (1978-12-01), Esanu
patent: 4176193 (1979-11-01), Esanu
patent: 4234599 (1980-11-01), Van Scott et al.
patent: 4671901 (1987-06-01), Green
patent: 4699926 (1987-10-01), Abraham et al.
patent: 4704402 (1987-11-01), Abraham et al.
patent: 4731381 (1988-03-01), Abraham et al.
patent: 4732914 (1988-03-01), Morton
patent: 4735967 (1988-04-01), Neesby
patent: 4751244 (1988-06-01), Abraham et al.
patent: 4822821 (1989-04-01), Perrine
patent: 4925873 (1990-05-01), Friedhoff et al.
patent: 4952560 (1990-08-01), Kigasawa et al.
patent: 5023251 (1991-06-01), Sattler et al.
patent: 5025029 (1991-06-01), Perrine
patent: 5039703 (1991-08-01), Breuer
patent: 5081124 (1992-01-01), Hughes
patent: 5137734 (1992-08-01), Spiegelman et al.
patent: 5185436 (1993-02-01), Villa et al.
patent: 5208333 (1993-05-01), Paul et al.
patent: 5378716 (1995-01-01), Hamanaka et al.
patent: 5403867 (1995-04-01), Okumura et al.
patent: 5674912 (1997-10-01), Martin
patent: 5679707 (1997-10-01), Okumura et al.
Krantis et al., 1989, "Augmentation of Cysteamine-Induced Ulceration", Dig. Dis. Sci. 34(8), pp. 1211-1216.
Nagai et al., 1971, "Studies on the Synergistic Action and Anti-Ulcerous", Arzneim-Forsch, 21(1), pp. 96-97.
Bourgeade et al., 1979, "Enhancement of Interferon Anti-tumor Action by Sodium Butyrate" Cancer Res., 39, pp.. 4720-4723.
M. Bugaut et al. Annu. Rev. Nutr. 13:217-41 (1993).
"Sodium n-butyrate enhancement of prostaglandin D.sub.2 antitumor efficacy", Biochemical Pharmacology, vol. 34, No. 20, pp. 3771-3774, 1985.
T. R. Breitman et al., Combinations of retinoic acid with either sodium butyrate, dimethyl, sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60, Cancer Research, vol. 50, pp. 6268-6273, Oct. 1, 1990.
A. Leder et al., Differential of Erythroleukemic Cells in the Presence of Inhibitors of DNA Synthesis, Science, vol. 190, pp. 893-894, Jul. 14, 1975.
C. Garre et al., Regulation of Acetylcholinesterase Expression in the K-562 Cell Line, Cancer Research, vol. 44, pp. 3749-3751, Sep., 1984.
L. Wasserman et al., Differential Effects of Sodium Butyrate and Dimethylsulfoxide on Gamma-Glutamyl Transpeptidase and Alkaline Phosphatase Activities in MCF-7 Breast Cancer Cells, Expl. Cell Biol., vol. 55, pp. 189-193, 1987.
M. Abe et al., Sodium Butyrate Induction of Milk-related Antigens in Human MCF-7 Breast Carcinoma Cells, Cancer Research, vol. 44, pp. 4574-4577, Oct., 1984.
N. F. Guilbaud et al., Effects of Differentiation-Inducing Agents on Maturation of Human MCF-7 Breast Cancer Cells, Journal of Cellular Physiology, vol. 145, pp. 162-172, 1990.
C. J. Ormandy et al., Coordinate Regulation of Oestrogen and Prolactin receptor expression by Sodium Butyrate in Human Breast Cancer Cells, Biochemical and Biophysical Research Communications, vol. 182, No. 2, pp. 740-745, Jan. 31, 1992.
J. R. Gum et al., Effects of Sodium Butyrate on Human Colonic Adenocarcinoma Cells, The Journal of Biological Chemistry, vol. 262, No. 3, p. 1092-1097, Issue of Jan. 25, 1987.
J. C. Byrd et al., Two Types of Transglutaminase in the PC12 Pheochromocytoma Cell Line, The Journal of Biological Chemistry, vol. 262, No. 24, pp. 11699-11705, Issue of Aug. 25, 1987.
S. H. Kim et al., Modification of thermosensitivity of HeLa Cells by Sodium Butyrate, Dibutyryl Cyclic Adenosine 3':5'-Monophosphate, and Retinoic Acid, Cancer Research, vol. 44, 697-702, Feb., 1984.
F. N. M. Naguib et al., Effects of N,N-Dimethylformamide and Sodium Butyrate on Enzymes of Pyrimidine Metabolism in Cultured Human Tumor Cells, Leukemia Research, vol. 11, No. 10, pp. 855-861, 1987.
J. R. Cook et al., Effect of Sodium Butyrate on .alpha.-Fetoprotein Gene Expression in Rat Hepatoma Cells in Vitro, Cancer Research, vol. 45, pp. 3215-3219, Jul., 1985.
C. Augeron et al., Emergence of Permanently Differentiated Cell Clones in a Human Colonic Cancer Cell Line in Culture after Treatment with Sodium Butyrate, Cancer Research, vol. 44, pp. 3961-3969, Sep., 1984.
S. P. Langdon et al., Effect of Sodium Butyrate and Other Differentiation Inducers of Poorly Differentiated Human Ovarian Adenocarcinoma Cell Lines, Cancer Research, vol. 48, pp. 6161-6165, Nov. 1, 1988.
D. Tsao et al., Differential Effects of Sodium Butyrate, Dimethyl Sulfoxide, and Retinoic Acid on Membrane-Associated Antigen, Enzymes, and Glycoproteins of Human Rectal Adenocarcinoma Cells, Cancer Research, vol. 42, pp. 1052-1058, Mar., 1982.
A. Morita et al., Effect of Sodium Butyrate on Alkaline Phosphatase in HRT-18, a Human Rectal Cancer Cell Line, Cancer Research, vol. 42, pp. 4540-4545, Nov., 1982.
J. D. Newman et al., Induction of the Insulin Receptor and Other Differentiation Markers by Sodium Butyrate in the Burkitt, Lymphoma Cell, Raji, Biochemical and Biophysical Research Communications, vol. 161, No. 1, pp. 101-106, May 30, 1989.
C. Rius et al., The Induction of Vimentin Gene Expression by Sodium Butyrate in Human Promonocytic Leukemia U937 Cells, Experimental Cell Research, vol. 188, pp. 129-134, 1990.
"Abstract", D.M. McCafferty et al., Int. J. Tissue React. 1989; 11(F): 165-8.
"Abstract", J.M. Harig et al., N. Engl. J. Med. Jan. 5, 1989; 320(1): 23-8.
"Abstract", D.M. McCafferty et al., Agents Actions 1992; Spec. No.: C79-81.
"Abstract", W. Scheppach et al., Gastroenterology Jul., 1992; 103(1): 336-8.
"Abstract", W.E. Roediger et al., Lipids Oct. 1990; 25(10): 646-52.
"Abstract", R.I. Breuer et al., Dig. Dis. Sci. Feb. 1991; 36(2): 185-7.
"Abstract", P. Planchon et al., In Vivo Nov.-Dec. 1992; 6(6) 605-10.
"Abstract", P. Planchon et al., Anticancer Res. Nov.-Dec. 1992; 12(6B): 2315-20.
"Abstract", S.J. Gaudet et al., Neurochem Int. Mar. 1993; 22(3): 271-5.
"Abstract", C.D. Gerharz et al., Clin. Exp. Metastasis Jan. 1993; 11(1): 55-67.
"Abstract", D. Garsetti et al., Biochem. J. Dec. 15, 1992; 228(pt 3): 831-7.
"Abstract", T. Boulikas, Anticancer Res. May-Jun. 1992; 12(3): 885-98.
"Abstract", M.M. Belcheva et al., J. Pharmacol. Exp Ther. Oct. 1991; 259(1): 302-9.
Randy A. Hock et al., "Retrovirus-mediated transfer and expression of drug resistance genes in human hematopoietic progenitor cells", Nature vol. 320, 20 Mar. 1986, pp. 275-277.
A. Novogrodsky, et al., "Effect of Polar Organic Componds on Leukemic Cells", American Cancer Society; vol. 51, Jan. 1, 1983; pp. 9-14.
J. Leavitt et al., "Butyric acid suppression of the in vitro neoplastic state of Syrian hamster cells", vol. 271, 19 Jan. 1978, pp. 262-265.
M.C. Hoessly et al., "Factors Responsible for Variable Reported Lineages of HL-60 Cells Induced to Mature with Butyric Acid", Cancer Research, 49, Jul. 1, 1989, 3594-97.
James Watson et al., "Butyric Acid In the Treatment of Cancer", The Lancet, Apr. 8, 1993, pp. 746-748.
Hans-Peter Bartram et al., "Proliferation of Human Colonic Mucosa as an Intermediate Biomarker of Carcinogenesis: Effects of Butyrate, Deoxycholate, Calcium, Ammonia, and pH", Cancer Research, 53, Jul. 15, 1993 pp. 3283-3288.
Charles Chany et al., "Antitumor Effect of Arginine Butyrate in Conjunction with Corynebacterium Parvum and Interferon", Int. J. Cancer: 30, (1982) pp. 489-493.
Charles Chany et al., "Effect of Coordinated Therapeutic Assays Using C. Parvum, Interferon and Arginine Butyrate on Spontaneous Disease and Survival of AKR Mice", Int. J. Cancer: 32, (1993) pp. 379-383.
H. Phillip Koeffler, Induction of Differentiation of Human Acute Myelogenous Leukemia Cells; Therapeutic Implications:, Blood, vol. 62, No. 4, Oct. 1983, pp. 709-721.
Michael Reiss et al., "Induction of Tumor Cells Differentiation as a Therapeutic Approach: Preclinical Models for Hematopoietic and Solid Neoplasms", Reports, vol. 70, No. 1, J

Affiliated with

Also associated with

Rating

Methods for the treatment of wounds using butyric acid salts and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the treatment of wounds using butyric acid salts and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of wounds using butyric acid salts and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1511946